Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05217446
Title A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer (SEAMARK)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer
Indications

colorectal carcinoma

Therapies

Pembrolizumab

Cetuximab + Encorafenib + Pembrolizumab

Age Groups: adult | child | senior
Covered Countries USA | ITA | ESP

Additional content available in CKB BOOST